Atlas Trials

Effects of Dapagliflozin+Saxagliptin in Addition to Metformin v/s Saxagliptin or Dapagliflozin in Patients With DM2.

Clinical trial NCT03714594 · COMPLETED

Trial details

NCT number
NCT03714594
Sponsor
University of Pisa
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Type2 Diabetes Mellitus
Start date
2018-07-24
Primary completion
2022-08-31
Enrollment
48

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.